The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the way this Amgen compound activates um the uh Gip receptor or inhibits the Gip receptor rather is that uh it's an antibody so all these other things were peptides but this is a much bigger sexual protein this is an antibody and because it's an antibody it has a much longer lifetime even than something like semaglutide which is 7 days so it last a month in the blood or something
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.